REPORTS

Let’s Pullulate and Expand Your Business

Specialty Pharmaceutical Market - Global Professional Analysis and Forecast to 2026

Nov 25, 2019  |  209 PAGES  |  REPORT CODE: CMM250021
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Specialty Pharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.

This report presents the market size and development trends by detailing the Specialty Pharmaceutical market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Specialty Pharmaceutical market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Specialty Pharmaceutical industry and will help you to build a panoramic view of the industrial development.

Specialty Pharmaceutical Market, By Type:

  • Antibody

  • Hormone

  • Growth Factors

Specialty Pharmaceutical Market, By Application:

  • Oncology

  • Inflammatory Conditions

  • Multiple Sclerosis

  • Growth Hormone

  • Other

Some of the leading players are as follows:

  • Lupin Ltd

  • Celgene Corporation

  • Biogen idec

  • Mylan

  • Sun Pharmaceuticals

  • Novartis

  • Johnson＆Johnson

  • Contura

  • Ajanta Pharma Limited.

  • Cipla

  • Allergan

  • Pfizer

  • Shire

  • King Pharmaceutical

  • Amgen

  • Teva Pharmaceutical Industries Ltd.

  • Gilead Sciences

  • Roche

  • Mallinckrodt

  • Abbvie Inc

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Specialty Pharmaceutical Market: Technology Type Analysis

  • 4.1 Specialty Pharmaceutical Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Specialty Pharmaceutical Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Antibody

    • 4.3.2 Hormone

    • 4.3.3 Growth Factors

5 Specialty Pharmaceutical Market: Product Analysis

  • 5.1 Specialty Pharmaceutical Product Market Share Analysis, 2018 & 2026

  • 5.2 Specialty Pharmaceutical Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Specialty Pharmaceutical Market: Application Analysis

  • 6.1 Specialty Pharmaceutical Application Market Share Analysis, 2018 & 2026

  • 6.2 Specialty Pharmaceutical Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Oncology

    • 6.3.2 Inflammatory Conditions

    • 6.3.3 Multiple Sclerosis

    • 6.3.4 Growth Hormone

    • 6.3.5 Other

7 Specialty Pharmaceutical Market: Regional Analysis

  • 7.1 Specialty Pharmaceutical Regional Market Share Analysis, 2018 & 2026

  • 7.2 Specialty Pharmaceutical Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Lupin Ltd

    • 9.1.1 Lupin Ltd Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Celgene Corporation

    • 9.2.1 Celgene Corporation Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Biogen idec

    • 9.3.1 Biogen idec Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Mylan

    • 9.4.1 Mylan Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Sun Pharmaceuticals

    • 9.5.1 Sun Pharmaceuticals Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Novartis

    • 9.6.1 Novartis Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Johnson＆Johnson

    • 9.7.1 Johnson＆Johnson Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Contura

    • 9.8.1 Contura Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Ajanta Pharma Limited.

    • 9.9.1 Ajanta Pharma Limited. Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Cipla

    • 9.10.1 Cipla Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Allergan

    • 9.11.1 Allergan Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Pfizer

    • 9.12.1 Pfizer Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Shire

    • 9.13.1 Shire Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 King Pharmaceutical

    • 9.14.1 King Pharmaceutical Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Amgen

    • 9.15.1 Amgen Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Teva Pharmaceutical Industries Ltd.

    • 9.16.1 Teva Pharmaceutical Industries Ltd. Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Gilead Sciences

    • 9.17.1 Gilead Sciences Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Roche

    • 9.18.1 Roche Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Mallinckrodt

    • 9.19.1 Mallinckrodt Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Abbvie Inc

    • 9.20.1 Abbvie Inc Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

 

The List of Tables and Figures (Totals 113 Figures and 159 Tables)

  • Figure Antibody Specialty Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Hormone Specialty Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Growth Factors Specialty Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Inflammatory Conditions market, 2015 - 2026 (USD Million)

  • Figure Multiple Sclerosis market, 2015 - 2026 (USD Million)

  • Figure Growth Hormone market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Specialty Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table North America Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table North America Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table North America Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Canada Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Canada Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Europe Specialty Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table Europe Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Europe Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Europe Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Germany Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Germany Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table France Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table France Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Italy Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Italy Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Spain Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Spain Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Specialty Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table China Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table China Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Japan Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Japan Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table India Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table India Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Specialty Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table MEA Specialty Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table MEA Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table MEA Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table MEA Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Specialty Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Specialty Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Specialty Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Lupin Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Celgene Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biogen idec Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sun Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson＆Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Contura Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ajanta Pharma Limited. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cipla Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Shire Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table King Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amgen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Gilead Sciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mallinckrodt Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbvie Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top